Artiva Biotherapeutics In...

NASDAQ: ARTV · Real-Time Price · USD
2.77
0.07 (2.59%)
At close: Aug 15, 2025, 3:59 PM
2.75
-0.54%
After-hours: Aug 15, 2025, 04:10 PM EDT

Artiva Biotherapeutics Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Net Income
-21.25M -20.31M -16.09M -17.47M -17.84M -13.96M -12M 11.28M -11.28M -16.72M
Depreciation & Amortization
-591K 628K 614K 627K 603K 587K 594K 556K 538K 578K
Stock-Based Compensation
1.55M 2.05M 2.18M 1.91M 1.48M 1.41M 1.39M 1.37M 2.46M 1.83M
Other Working Capital
1.44M -1.44M -784K 1.54M 685K 45K -881K -24.8M -1.78M 388K
Other Non-Cash Items
-4.17M -723K -1.04M 318K 2.08M n/a 424K -159K n/a n/a
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
1.49M -1.49M -311K 3.01M -7K -3.02M -1.09M -23.8M -3.46M 64K
Operating Cash Flow
-22.98M -19.84M -14.65M -11.61M -13.69M -15.09M -10.68M -10.75M -11.76M -14.24M
Capital Expenditures
-1.05M -511K -64K -96K -464K -18K -636K -179K -581K -1.86M
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-6.07M -18.52M -14.85M -142.93M -12.19M -6.2M -14.83M -12.31M -22.37M n/a
Sales Maturities Of Investments
28.25M 29M 13.95M 12.4M 14M 16M 12.8M 12M 2M n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow
21.12M 9.97M -966K -130.63M 1.35M 9.78M -2.67M -493K -20.95M -1.86M
Debt Repayment
n/a -33K -33K -38K n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a -4.18M n/a n/a n/a n/a n/a n/a -12K
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-39K 272K 4.19M -2.6M -1.62M n/a 962K 23.43M 10K n/a
Financial Cash Flow
-72K 239K -30K 163.87M -1.62M n/a 962K 23.43M 10K -12K
Net Cash Flow
-1.93M -9.63M -15.65M 21.63M -13.95M -5.3M -12.38M 12.19M -32.71M -16.12M
Free Cash Flow
-24.04M -20.35M -14.71M -11.71M -14.15M -15.1M -11.31M -10.93M -12.35M -16.11M